44 reports

  • Global epinephrine autoinjector market by age group 2016
  • Market segmentation by age group

For children above ## years of age, the anaphylactic shocks can happen due to different etiologies like asthma, drug allergies and are also common in people with a family history of anaphylaxis.

  • Cardiovascular Drug
  • World
  • Impax Laboratories, Inc.
  • Lincoln Medical, Ltd.
  • Mylan Inc.

Spiriva is used to treat chronic obstructive pulmonary disease (COPD) and asthma.

  • Cardiovascular Drug
  • World
  • Market Size
  • Bayer AG
  • Daiichi Sankyo Company
  • ACE INHIBITOR SWOT ANALYSIS, 2015
  • ARB SWOT ANALYSIS, 2015

BETA BLOCKERS CAN EXACERBATE THE SYMPTOMS OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DUE TO THE SIMILARITIES BETWEEN THE BETA ADRENOCEPTOR IN THE HEART AND BETA ADRENOCEPTOR IN THE LUNGS. ##. ##. ##. ##. ## Safety Competitive Assessment ##. ##. ##. ##. ## SWOT Analysis TABLE ## PROVIDES A SWO

  • Cardiovascular Drug
  • World
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GLOBAL BETA-ADRENERGIC BLOCKERS MARKET

The market is growing at a slower pace than the calcium channel blockers market owing to intolerance among the individuals with asthma, and who have a high risk of developing an ischemic heart attack.

  • Cardiovascular Drug
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.

OTHER MEDICAL CONDITIONS ALSO ASSOCIATED WITH AF INCLUDE DIABETES, HYPERTHYROIDISM, PNEUMONIA, PULMONARY EMBOLISM (PE), LUNG CARCINOMA, AND CHRONIC LUNG DISEASES SUCH AS ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD).

  • Cardiovascular Drug
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company
  • Pfizer Inc.
  • ANTI-HYPERTENSIVE THERAPEUTICS, COMPELLING AND POSSIBLE CONTRA-INDICATIONS OF
  • 3.5 Beta Blockers

Coreg is contraindicated in patients with bronchial asthma or related bronchospastic conditions, second- or third-degree atrioventricular block, sick sinus syndrome or severe bradycardia, Carvedilol' s patent has expired, and generic forms are available in India, Japan, Australia and Ch

  • Cardiovascular Drug
  • World
  • Market Size
  • Daiichi Sankyo Company
  • Novartis AG

Some forms of chronic lung disease affect many people in UK and most commonly are chronic obstructive pulmonary disease and asthma.

  • Cardiovascular Drug
  • Prescription Drug
  • China
  • Demand
  • Supply

THE COMPANY MAINLY SELLS DRUGS TREATING HBV, ASTHMAS AND INFECTIONS.

  • Cardiovascular Drug
  • China
  • Demand
  • Supply
  • Zhejiang Expressway Co., Ltd.

emphysema, bronchitis, asthma), Restrictive conditions (e. g., fibrosis, sarcoidosis, alveolar damage, pleural effusion), Vascular diseases (e. g., pulmonary edema, pulmonary embolism, pulmonary hypertension), Infectious, environmental and other " diseases" (e. g., pneumonia, tuber

  • Cardiovascular Drug
  • China
  • Demand
  • Forecast
  • Market Size

asthma), Xieke® Valsartan capsule (Antihypertensive), Danke® Risperidone tablet(anti-schizophrenic), Hengke® Glipizide controlled-release tablet (anti-diabetic), Jinyike® ##-peptide Somatostatin, Fentaike® Fentanyl patch (pain-release), Jiabeike® Gabexate (treatment of pancreatitis), etc.

  • Cardiovascular Drug
  • China
  • Demand
  • Market Size
  • Sanofi-Synthelabo Inc.
  • Anticoagulants pipeline portfolio

The drug candidate is in the preclinical stage of development for COPD, cystic fibrosis, and asthma.

  • Cardiovascular Drug
  • United States
  • Boehringer Ingelheim GmbH
  • Johnson & Johnson
  • Sanofi S.A.

asthma), Xieke® Valsartan capsule (Antihypertensive), Danke® Risperidone tablet(anti-schizophrenic), Hengke® Glipizide controlled-release tablet (anti-diabetic), Jinyike® ##-peptide Somatostatin, Fentaike® Fentanyl patch (pain-release), Jiabeike® Gabexate (treatment of pancreatitis), etc.

  • Cardiovascular Drug
  • China
  • AstraZeneca China Inc.
  • Hangzhou MSD Pharmaceutical Co., Ltd
  • Sanofi-Synthelabo Inc.

About ## in ## people (about ## Million) with asthma had an asthma attack in 2008, but many asthma attacks could have been prevented.

  • Cardiovascular Drug
  • Pharmaceutical
  • United States
  • Forecast
  • Pfizer Inc.

The segment is expected to grow at a rapid pace during the forecast period as most of the drugs for asthma and COPD are set to lose patent protection by 2016.

  • Anti-Infective
  • Cardiovascular Drug
  • Japan
  • Meiji Seika Pharma Co., Ltd.
  • Nipro Corporation
  • Competitive Landscape of Benazepril Market in 2013
  • Competitive Landscape of Felodipine Market in 2013

It is suitable for hypertensive patients which diabetes, renal insufficiency and asthma.

  • Cardiovascular Drug
  • China
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • FM-101 - DRUG PROFILE
  • Adenosine Receptor A3 (ADORA3) - Dormant Products

Asthma, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease (COPD), Colon Cancer, Diabetic Nephropathy, Erectile Dysfunction, Glomerulonephritis, Hepatocellular Carcinoma, Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), Irritable Bowel Syndrome, Kidney Fibrosis,

  • Arthritis
  • Cardiovascular Drug
  • Hepatitis
  • Therapy
  • Can-Fite BioPharma Ltd.

Risk factors include personal history of anaphylaxis, allergies or asthma and family history.

  • Cardiovascular Drug
  • Hormone
  • United States
  • World
  • Product Initiative
  • ANAPHYLAXIS - PIPELINE BY MANNKIND CORP, H1 2017
  • ANAPHYLAXIS - PIPELINE BY ADAMIS PHARMACEUTICALS CORP, H1 2017

Risk factors include personal history of anaphylaxis, allergies or asthma and family history.

  • Cardiovascular Drug
  • Hormone
  • United States
  • Product Initiative
  • Adamis Pharmaceuticals Corporation
  • Cardiovascular Drug
  • Therapy
  • World
  • Product Initiative
  • Can-Fite BioPharma Ltd.

Asthma Control in Adult Subjects with Persistent Asthma Controlled on Stable, Low-dose, Inhaled Corticosteroids A Study to Determine the Effect of SB-## on Asthma GDCT## NCT##, LPL## Cardiovascular Atherosclerosis (Leukotriene E## (LTE##), P Selectin (CD##

  • Cardiovascular Disease
  • Cardiovascular Drug
  • Clinical Trial
  • Lipid Modifying Drug
  • World

Asthma, Chronic Obstructive Pulmonary Disease (COPD), Eisenmenger Syndrome, Hypoxemia, Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease), Pulmonary Embolism, Pulmonary Hypertension, Rheumatic Disorders Completed Phase II Interventional sodium nitroprusside Defence Research &

  • Cardiovascular Drug
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative

Asthma in Pediatric Emergency Ward Comparison of Two Different Corticoids Treatments with Power and Administration on the Treatment of in Children with Acute Asthma in Pediatric Emergency GDCT## EudraCT-2013-##-##, Respiratory Apnea, Asthma, Bronchospasm, Cough, w

  • Cardiovascular Drug
  • Clinical Trial
  • Therapy
  • World
  • Teva Pharmaceutical Industries Ltd.

ASTHMA PATIENTS EFFECT OF INTRAVENOUS RECOMBINANT HUMAN APC ON COAGULATION AND INFLAMMATION IN HOUSE DUST MITE AND LIPOPOLYSACCHARIDE INDUCED ALLERGIC ASTHMA GDCT## NTR##, NL##. ##. ##; 2011_###C##; CCMO / MEC AMC HEMATOLOGICAL DISORDERS ALLERGIC ASTHMA,

  • Cardiovascular Drug
  • Clinical Trial
  • World
  • Product Initiative
  • Bayer AG

Asthma, Congestive Heart Failure (Heart Failure), Cough, Edema, Fatigue, Nasopharyngitis (Common Cold) Planned Phase I Observational Jiashen Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine; Tasly Pharmaceutical Group Co Ltd ## Jul 2017 ## Jul 2018 ## ## ## Offi

  • Cardiology
  • Cardiovascular Drug
  • Clinical Trial
  • World
  • Product Initiative

Asthma Control in Adult Subjects with Persistent Asthma Controlled on Stable, Low-dose, Inhaled Corticosteroids A Study to Determine the Effect of SB-## on Asthma GDCT## NCT##, LPL## Cardiovascular Asthma, Atherosclerosis (Platelet Activating Fa

  • Cardiovascular Disease
  • Cardiovascular Drug
  • Chronic Disease
  • Pharmaceutical
  • World

Asthma, Congestive Heart Failure (Heart Failure), Cough, Edema, Fatigue, Nasopharyngitis (Common Cold) Planned Phase I Observational Jiashen Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine; Tasly Pharmaceutical Group Co Ltd ## Jul 2017 ## Jul 2018 ## ## ## Heal

  • Cardiovascular Drug
  • Clinical Trial
  • Cytokine
  • World
  • Teva Pharmaceutical Industries Ltd.

Asthma, Lung Cancer, Sleep Apnea Withdrawn Phase II Interventional undisclosed anti-cancer drug; undisclosed steroid Kobe University Japan Science and Technology Agency ## Jul 2009 ## ## ## ## ## Sodium Dependent Noradrenaline Transporter (Norepinephrine Transporter or NET or Solute Carrier Fa

  • Cardiovascular Drug
  • Clinical Trial
  • World
  • Product Initiative
  • Teva Pharmaceutical Industries Ltd.

Asthma, Chronic Cough, Emesis (Vomiting), Reflux Esophagitis (Gastroesophageal Reflux Disease) Completed Phase II Interventional Gastrotuss baby syrup; lansoprazole Federico II University ## Feb 2013 ## Dec 2013 ## ## ## ## ## Clinical Trial profile. ## Trial Title Official Title Trial Ident

  • Cardiovascular Drug
  • Digestive System Disorder
  • Pharmaceutical
  • World
  • Product Initiative
  • IDIOPATHIC (ESSENTIAL) HYPERTENSION - PIPELINE BY SUN PHARMA ADVANCED RESEARCH COMPANY LTD., H1 2016

Its products in preclinical studies include Sun K##, a novel tyrosine kinase inhibitor for the treatment of CML; Sun ##, a topical glucocorticoid for the treatment of allergic rhinitis, asthma and other indications; and L##, a highly selective and potent LTD## antagonist for the treatmen

  • Cardiovascular Drug
  • Hypertension
  • Pharmaceutical
  • United States
  • Product Initiative

Vital Diagnostics, Inc. - Product Pipeline Analysis, 2015 Update REFERENCE CODE: GDME##PD PUBLICATION DATE: DECEMBER 2015 LIST OF TABLES VITAL DIAGNOSTICS, INC.

  • Cardiovascular Drug
  • In Vitro Diagnostics
  • United States
  • World
  • Product Initiative